Axon Enterprise, Inc. (NASDAQ:AXON) Shares Acquired by Sumitomo Mitsui DS Asset Management Company Ltd

Sumitomo Mitsui DS Asset Management Company Ltd lifted its stake in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) by 10.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 8,200 shares of the biotechnology company's stock after acquiring an additional 809 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd's holdings in Axon Enterprise were worth $4,873,000 as of its most recent SEC filing.

A number of other large investors have also made changes to their positions in AXON. New Wave Wealth Advisors LLC purchased a new position in Axon Enterprise during the fourth quarter worth about $40,000. Y.D. More Investments Ltd purchased a new position in Axon Enterprise during the fourth quarter worth about $45,000. Prestige Wealth Management Group LLC lifted its position in Axon Enterprise by 115.8% during the third quarter. Prestige Wealth Management Group LLC now owns 82 shares of the biotechnology company's stock worth $33,000 after buying an additional 44 shares during the period. GPS Wealth Strategies Group LLC raised its holdings in shares of Axon Enterprise by 74.1% in the 4th quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock worth $56,000 after purchasing an additional 40 shares during the period. Finally, Versant Capital Management Inc raised its holdings in shares of Axon Enterprise by 4,750.0% in the 4th quarter. Versant Capital Management Inc now owns 97 shares of the biotechnology company's stock worth $58,000 after purchasing an additional 95 shares during the period. Institutional investors and hedge funds own 79.08% of the company's stock.

Insiders Place Their Bets

In other Axon Enterprise news, Director Michael Garnreiter sold 1,000 shares of the firm's stock in a transaction on Monday, December 16th. The shares were sold at an average price of $639.69, for a total transaction of $639,690.00. Following the completion of the transaction, the director now directly owns 24,259 shares of the company's stock, valued at $15,518,239.71. This trade represents a 3.96 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Julie A. Cullivan sold 1,261 shares of Axon Enterprise stock in a transaction dated Wednesday, December 4th. The shares were sold at an average price of $682.06, for a total transaction of $860,077.66. Following the completion of the transaction, the director now directly owns 2,392 shares of the company's stock, valued at $1,631,487.52. This trade represents a 34.52 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 50,545 shares of company stock valued at $30,721,337 in the last ninety days. Corporate insiders own 6.10% of the company's stock.

Axon Enterprise Stock Down 0.2 %

Axon Enterprise stock traded down $1.39 during midday trading on Monday, hitting $677.85. 432,359 shares of the stock were exchanged, compared to its average volume of 572,279. Axon Enterprise, Inc. has a 1 year low of $255.68 and a 1 year high of $698.67. The firm has a market cap of $51.69 billion, a P/E ratio of 175.16, a P/E/G ratio of 6.79 and a beta of 1.05. The company has a debt-to-equity ratio of 0.32, a current ratio of 2.96 and a quick ratio of 2.63. The company has a 50 day moving average price of $624.26 and a two-hundred day moving average price of $498.90.

Analysts Set New Price Targets

A number of research firms have recently commented on AXON. The Goldman Sachs Group raised their price objective on Axon Enterprise from $500.00 to $700.00 and gave the stock a "buy" rating in a report on Monday, January 27th. Robert W. Baird raised their price objective on Axon Enterprise from $600.00 to $800.00 and gave the stock an "outperform" rating in a report on Friday, December 6th. Morgan Stanley upgraded Axon Enterprise from an "equal weight" rating to an "overweight" rating and raised their price objective for the stock from $500.00 to $700.00 in a report on Tuesday, December 3rd. Needham & Company LLC raised their price objective on Axon Enterprise from $525.00 to $600.00 and gave the stock a "buy" rating in a report on Friday, November 8th. Finally, Northland Securities raised their price objective on Axon Enterprise from $365.00 to $550.00 and gave the stock an "outperform" rating in a report on Monday, November 11th. One research analyst has rated the stock with a hold rating and fourteen have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of "Moderate Buy" and a consensus target price of $542.15.

Axon Enterprise Profile

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.